Verona Pharma PLC (VRNA)
37.93
-0.92
(-2.37%)
USD |
NASDAQ |
Nov 21, 16:00
37.93
0.00 (0.00%)
After-Hours: 20:00
Verona Pharma Market Cap: 3.104B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.179B |
| November 19, 2024 | 3.117B |
| November 18, 2024 | 2.859B |
| November 15, 2024 | 2.918B |
| November 14, 2024 | 2.894B |
| November 13, 2024 | 3.022B |
| November 12, 2024 | 3.191B |
| November 11, 2024 | 3.263B |
| November 08, 2024 | 3.157B |
| November 07, 2024 | 3.124B |
| November 06, 2024 | 3.076B |
| November 05, 2024 | 3.141B |
| November 04, 2024 | 3.122B |
| November 01, 2024 | 2.862B |
| October 31, 2024 | 2.777B |
| October 30, 2024 | 2.798B |
| October 29, 2024 | 2.755B |
| October 28, 2024 | 2.709B |
| October 25, 2024 | 2.771B |
| October 24, 2024 | 2.817B |
| October 23, 2024 | 2.858B |
| October 22, 2024 | 2.853B |
| October 21, 2024 | 2.862B |
| October 18, 2024 | 2.834B |
| October 17, 2024 | 2.836B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.785B |
| October 15, 2024 | 2.788B |
| October 14, 2024 | 2.804B |
| October 11, 2024 | 2.674B |
| October 10, 2024 | 2.567B |
| October 09, 2024 | 2.598B |
| October 08, 2024 | 2.600B |
| October 07, 2024 | 2.623B |
| October 04, 2024 | 2.619B |
| October 03, 2024 | 2.521B |
| October 02, 2024 | 2.349B |
| October 01, 2024 | 2.372B |
| September 30, 2024 | 2.354B |
| September 27, 2024 | 2.336B |
| September 26, 2024 | 2.245B |
| September 25, 2024 | 2.296B |
| September 24, 2024 | 2.409B |
| September 23, 2024 | 2.405B |
| September 20, 2024 | 2.436B |
| September 19, 2024 | 2.388B |
| September 18, 2024 | 2.375B |
| September 17, 2024 | 2.371B |
| September 16, 2024 | 2.450B |
| September 13, 2024 | 2.419B |
| September 12, 2024 | 2.436B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.44M
Minimum
Mar 18 2020
3.263B
Maximum
Nov 11 2024
843.17M
Average
476.27M
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals PLC | 2.532M |
| TC BioPharm (Holdings) PLC | 0.3115M |
| Adaptimmune Therapeutics PLC | 162.23M |
| NuCana PLC | 2.853M |
| Autolus Therapeutics PLC | 754.46M |
Market Cap Related Metrics
| PEG Ratio | -0.0737 |
| Price to Book Value | 23.79 |
| Price | 37.93 |
| Earnings Yield | -5.27% |
| PEGY Ratio | -0.0737 |